Endo 16: Type II diabetes mellitus Flashcards

1
Q

Define Diabetes Mellitus

A

State of chronic hyperglycemia sufficient to cause long term damage to specific tissues, notably the retina, kidneys, nerves + arteries

note: fasting glucose level >7mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are 3 major factors that influence the pathophysiology of T2DM ?

A
  • genetics
  • intrauterine environment (causes epigenetic changes )
  • adult environment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Insulin resistance + insulin secretion defects causes :

A

T2DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is MODY?

A
  • maturity onset diabetes of the young
  • autosomal dominant
  • -> involves mutation of transcription factor genes glucokinase genes
  • -> single gene hereditary condition

–> ineffective pancreatic B-cell insulin production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Insulin leads to _______
which stimulates the mitogenic pathway

what is the effect of this?

A

Insulin leads to DYSLIPIDAEMIA
which stimulates the mitogenic pathway

effect:
- causes smooth muscle cell hypertrophy
- -> causes increase in BP
- -> can cause microvascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is low birth rate linked to diabetes?

A
  • low birth weight increase risk of impaired glucose tolerance + diabetes

–> epigenetic effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

As we age, we secrete more / less insulin

and we become more/ less insulin resistant

A

As we age, we secrete more insulin

because with age we become more insulin resistant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How might T2DM present?

A
  • obesity
  • insulin resistance
  • insulins secretion deficiency
  • hyperglycemia
  • dyslipidaemia
  • acute/chronic complication
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does insulin lower blood glucose level?

A
  • by reducing HGO
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what happens to HGO before and after a meal ?

A

before meal = HGO maintains blood glucose level at 4 mmol/L

after meal = insulin stops HGO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

IN T2DM:

THERE IS INSUFFICIET INSULIN TO INHIBIT HGO + INSUFFICIENT INSULIN TO MOVE GLUCOSE INTO MUSCLE + FAT

A

-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the relationship between insulin sensitivity + insulin secretion in NORMAL individuals?

A

with age insulin sensitivity decreases
–> so insulin secretion increases to maintain normal blood glucose levels

i.e insulin resistance increases with age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the relationship between insulin sensitivity + insulin secretion in DIABETIC individuals?

A

with age insulin sensitivity decreases

–> but can’t increase insulin secretion sufficiently

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are major effects of insulin resistance?

A
  • there is an increase HGO

- there is a decrease in glucose uptake into tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

perturbation in gut microbiota

A

bacteria in gut modulates intermediary metabolism

  • associate with obesity, T2DM
  • involved in host signaling
  • involved in bacterial lipopolysaccharides fermentation to short chain FA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is a common side effect of diabetes treatments

except:

A
  • weight gain

except metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How might T2DM present?

A
  • osmotic symptoms
  • infections
  • screening test

if with complication

  • acute: hyperosmolar coma
  • chronic: Ischaemic heart disease, retinopathy
18
Q

What are some microvascular complications associated with T2DM ?

A
  • retinopathy
  • nephropathy
  • neuropathy
19
Q

What are some macrovascular complications associated with T2DM ?

A
  • ischemic heart disease
  • cerebrovascular
  • renal artery stenosis
20
Q

What are some metabolic complications associated with T2DM ?

A
  • lactic acidosis

- hyperosmolar

21
Q

How would you manage T2DM?

A
  • educate
  • change diet
  • pharmacological treatment
  • complication screening
22
Q

How would you change lifestlyle/diet of patients with T2DM?

A
  • increase exercise
  • reduce refined carb
  • increase complex carb
  • reduce fat
  • increase unsaturated fat proportion
  • increase soluble fibre
  • less salt
23
Q

How does Metformin act as a treatment method for T2DM?

A
  • biguanide
  • acts on LIVER
  • reduced insulin resistance
  • -> reduces HGO
  • -> increases peripheral glucose disposal

note:
avoid if severe liver/heart/ mild renal failure

24
Q

How does Sulphonylurea act as a treatment method for T2DM?

A
  • they block the ATP sensitive K+ channel in Beta cell
  • which causes depolarization
  • activates VGCC
  • causes Ca2+ influx
  • which causes insulin secretion
25
How does Acarbose act as a treatment method for T2DM?
- acarbose = alpha glucosidase inhibitor - prolongs absorption of oligosccharides - allows insulin secretion to cope after loss of 1st phase insulin response
26
What is a major side effect of acarbose?
- flatus
27
How do Thiazolidinediones act as a treatment method for T2DM?
Thiazolidinediones = peroxisome proliferator activated receptor (PPAR-gamma) agonists - they are insulin sensitisers - increases glucose uptake in muscles e.g pioglitazone
28
How do GLP-1 act as a treatment method for T2DM?
- it acts to stimulate insulin + suppress glucagon - it restores B-cell glucose sensitivity - decreases glucagon conc - decreases glucose conc --> GLP-1 = injectable
29
What is the dilemma with GLP-1 and how is this overcome?
dilemma: GLP -1 has short half life --> due to rapid degradation by DPP4 overcome by gliptins: - gliptins = DPP4 inhibitors - -> increases half life of exogenous GLP-1
30
note: other aspects of control - BP - diabetic dyslipidaemia
-
31
Compare between T1DM vs T2DM
T1DM - prevalence = lower - onset: acute in children/teens - often thin - uncommon family history - ketosis prone - HLA association: DR3, DR4 - Islet Bcell = destroyed T2DM - prevalence = higher - onset: gradual in middle age - often obese - common family history - NOT ketosis prone - NO HLA association - islet Bcell = functioning
32
note: Fasted glucose level < 6 mmol/L = normal faster glucose level after 2 hours < 7.8 mmoL = normal
-
33
glucose has
- mitogenic pathway - metabolic dyslipidaemia --> both can lead to macrovascular diseases
34
note: 70% of monozygous twins = will have T2D | 40% of dizygous twin = will have T2D
-
35
In T2DM --> insulin administration is more/less effective in controlling blood glucose levels
In T2DM --> insulin administration is LESS effective in controlling blood glucose levels
36
insulin switches off lipolysis - Tri glycerol(TG) broken down to glycerol --> glucose - glucose can't be taken up into the muscle --> so there is high level of glucose in the blood then NEFA comes in --> forms VLDL - TG --> there is increase in small dense VLDL (which is atheromatic)
-
37
NOTE: FAT IS AN ENDOCRINE SYSTEM ---> produces hormones
-
38
Central obesity = more/less risky than peripheral obesity why?
Central obesity = more risky than peripheral --> due to effect of metabolism effects of the liver
39
what is orlistat
- GI lipase inhibitor
40
how are SGLT2 inhibitors used to in T2DM
acts on kidney blocks uptake of glucose so glucose in excreted (glycosuria) -- > and they also lower mortality (esp heart failure)